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Ligusticum chuanxiong (LC)eGastrodia elata (GE) compatibility is widely used in the clinic for
the treatment of migraine. It has been shown that the changes of neurotransmitters in the
central nervous system are closely related to the pathogenesis of migraine; whether LCeGE
compatibility might affect the neurotransmitters in migraine rats has not yet been studied.
In this study, high performance liquid chromatography-fluorescence detector methods for
quantification of serotonin (5-hydroxytryptamine, 5-HT) and excitatory amino acids (EAAs)
in rat brain were developed. The 5-HT was measured directly, while EAAs were determined
by using dansyl chloride as precolumn derivative reagent. The validation of the methods,
including selectivity, linearity, sensitivity, precision, accuracy, recoveries, and stability
were carried out and demonstrated to meet the requirements of quantitative analysis.
Compared with the model group, the expression of 5-HT in migraine rat brain was
enhanced from 30 minutes to 120 minutes and glutamate (L-Glu) was suppressed from 30
minutes to 60 minutes in an LCeGE (4:3) group compared with the model group (p < 0.05,
p < 0.01, respectively). These findings showed that the analytical methods were simple,
sensitive, selective, and low cost, and LCeGE 4:3 compatibility could have better efficacy for
treating migraine through upregulating 5-HT levels and downregulating L-Glu levels.
Copyright © 2015, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).al Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Room 10405,
, China.
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inistration, Taiwan. Published by Elsevier Taiwan LLC. This is an open access article under the CC
/licenses/by-nc-nd/4.0/).
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 1 8 9e1 9 81901. Introduction
Migraine is a chronic trigeminal pain condition that affects the
daily lives of a large part of our population [1]. Recent clinical
and experimental evidence has shown that the changes of
serotonin (5-hydroxytryptamine, 5-HT) and excitatory amino
acids (EAAs) in the central nervous system (CNS) might be
critical mediators in the pathogenesis of migraine [2]. 5-HT is
involved in the regulation of both physiological and
pathophysiological conditions in tissues throughout the body;
and the other two neurotransmitters namely 5-
hydroxytryptophan (5-HTP) and 5-hydroxyindoleacetic acid
(5-HIAA; Fig. 1) are its direct precursor and metabolite,
respectively [3,4]. It is confirmed that cerebral vasodilation
and low serotonin levels are the possible pathogenesis of
migraine, meanwhile, several receptors including 5-HT1, 5-
HT2 and 5-HT3 are associated with migraine [5]. 5-HT and
related compounds could inhibit N-methyl D-aspartate
(NMDA) receptors and attenuate glutamate (L-Glu)-mediated
excitatory synaptic responses in a concentration dependent
manner, which may play a role in the protection of the
bloodebrain barrier (BBB) [6]. In addition, the amino acids L-
Glu and aspartate (L-Asp; Fig. 1) are recognized as the major
excitatory neurotransmitters in the CNS. They may activate
NMDA receptors and decrease the phosphorylation of insulin-
like growth factors-1 (IGF-1) receptors, and amplify and rein-
force pain transmission and brain damage. Therefore, NMDA
antagonists are important neuroprotectors that could reduce
excitotoxicity, and restrain the excessive release of EAAs and
their intracellular effects [7]. It has been proven that the
changes of neurotransmitters in the CNS are closely related to
the pathogenesis of migraine, and the determination of 5-HT
and EAAs in the brain could provide evidence to explore the
pathological mechanism of migraine.
Currently many bioanalytical techniques have been
developed for the analysis of 5-HT and EAAs. gas chroma-
tography (GC) [8,9], capillary electrophoresis (CE) [10,11] andFig. 1 e Chemical structures of all the analytes. (A) 5-hydroxytr
hydroxyindoleacetic acid (5-HIAA); (D) glutamate (L-Glu); and (Eliquid chromatography-electrochemical [12] have been re-
ported to determine neurotransmitters levels. However, most
of these methods are complex and require higher costs.
Amino acid levels are determined using an automatic amino
acid analyzer traditionally [13]. In recent years, themajority of
methods that have been reported for determination of amino
acids are based on precolumn derivatization, and derivatiza-
tion reagents such as O-phthalaldehydes [14], phenyl iso-
thiocyanate [15], 9-fluorenylmethyl chloroformate [16], and
dansyl chloride (DNS-Cl) [17], etc. are abundant. However,
some derivatization reagents would shorten the life of the
analytical column, could not be detected by fluorescence
detection, react with secondary amino acids, and their de-
rivatives are not stable either. Therefore, DNS-Cl derivatiza-
tion is chosen for its simplicity, selectivity, sensitivity,
accuracy, and economy. Thus, simple, economical, and rapid
methods will be established to determine 5-HT and EAAs in
rat brain.
Ligusticum chuanxiong (LC)eGastrodia elata (GE) 1:3, 2:3 and
4:3 compatibility are commonly used for treating migraine
from clinical application and ancient books. Preliminary
studies show that LC and GE ethanol extracts are the main
therapeutically effective parts; on this basis, active compo-
nents of LC and GE are obtained [18]. It has been demon-
strated that ligustilide (i.e., senkyunolide I) and organic acids
(i.e., ferulic acid) from LC as well as gastrodin from GE are the
main active components for the treatment of migraine, an
antimigraine effect of which has also been suggested by
previous studies [19e22]. However, whether different dose-
ratios of LCeGE compatibility could affect the neurotrans-
mitters in migraine rats has not yet been studied. In the
current study, different dose-ratios of LC and GE were given
to 6-week-old SpragueeDawley rats orally. The effects of
different dose-ratios of LC and GE on the content of 5-HT and
EEAs in migraine rats were systematically profiled. Thus, the
possible compatibility mechanism of the two herbs may be
found.yptophan (5-HTP); (B) 5-hydroxytryptamine (5-HT); (C) 5-
) aspartate (L-Asp).
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2.1. Chemicals and reagents
Active components of LC and GE were both extracted with
ethanol and further purified with macroporous resin and pH
precipitation, respectively. The yield of the LC extract was
1.44%, which contained 6.20% of ferulic acid and 10.74% of
senkyunolide I. The yield of the GE extract was 5.68%, which
contained 14.85% of gastrodin. The codergocrine mesylate
(CDM) tablets and nitroglycerin injection were purchased
from Tianjin Huajin Pharmaceutical Co. Ltd. (Tianjin, China)
and Beijing Yimin Pharmaceutical Co. Ltd. (Peking, China),
respectively. 5-HTP, 5-HIAA and 5-HT were obtained from
Sigma-Aldrich (Shanghai, China). L-Glu and L-Asp were from
SinopharmChemical Reagents (Shanghai, China). DNS-Cl was
from Tokyo Chemical Industry (Tokyo, Japan). High perfor-
mance liquid chromatography (HPLC) grade acetonitrile and
methanol were purchased from Merck, Inc. (Darmstadt, Ger-
many). All other chemical solvents were of analytical grade
from Sinopharm Chemical Reagents.
2.2. Instrument and analytical conditions
2.2.1. HPLC analysis for 5-HTP, 5-HT, and 5-HIAA
HPLC analysis for 5-HTP, 5-HT, and 5-HIAA was performed on
an Agilent 1200 HPLC apparatus, equipped with fluorescence
detector (Agilent technologies, Santa Clara, CA, USA). The
column used was ZORBAX SB-C18, 5 mm, 4.6 mm  250 mm
(Agilent technologies). The mobile phase was composed of
methanol:acetate buffer (pH 5.1; 0.1M; 8:92%, v/v) at a flow rate
of 1.0 mL/min. Acetate buffer was prepared by dissolving
8.20 g of sodiumacetate and 33.62mg of sodium-EDTA in 1 L of
triple-distilled water, and its pH was adjusted to 5.1 with
acetic acid. The column was heated to 25C and the three
neurotransmitters were detected by their fluorescence at an
emission wavelength of 330 nm and excitation at 290 nm.
2.2.2. HPLC analysis for L-Glu and L-Asp
The chromatographic system and the column for measuring
L-Glu and L-Asp were of the same composition as described
above. The flow rate was 0.8 mL/min and the temperature of
the column oven was maintained at 30C. The derivatized
DNS-amino acids were detected by their fluorescence at an
emission wavelength of 515 nm and excitation at 340 nm.Fig. 2 e Simplified reaction scheme for the derivatization of
excitatory amino acids (EAAs) with dansyl chloride (DNS-
Cl).Acetonitrile (A) and ammonium acetate buffer (B: (pH 3.5;
5mM) were used for gradient elution; the ammonium acetate
buffer was prepared by dissolving 0.39 g of ammonium ace-
tate, 0.96 g of citric acid, 64.47 mg of tetrabutyl ammonium
bromide, and 16.81 mg of sodium-EDTA in 1 L of triple-
distilled water, and its pH was adjusted to 3.5 with formic
acid. The initial elution condition was A:B (20:80, v/v), then
linearly changed to A:B (25:75, v/v) at 3minutes, A:B (30:70, v/v)
at 10 minutes, A:B (32:68, v/v) at 16 minutes, A:B (33:67, v/v) at
25 minutes, and A:B (20:80, v/v) at 28 minutes.
2.3. Preparation of reference standards solutions
Aqueous stock solutions of 5-HTP (124.00 mg/mL), 5-HT
(40.00 mg/mL), 5-HIAA (110.00 mg/mL), L-Glu (182.40 mg/mL),
and L-Asp (102.20 mg/mL) were prepared in 0.1M hydrochloric
acid and aliquoted to a brown volumetric flask. These solu-
tions were diluted daily to working concentrations with 0.1M
hydrochloric acid. All solutions were stored at 4C in the dark.
2.4. Preparation of sample solutions
The CDM tablets (each tablet contains 1 mg codergocrine)
prepared in physiological saline and diluted to 0.1 mg/mL
CDM solution were used as the positive drug. The extracts of
LC and GE were mixed with the weight ratios of 1:3, 2:3, and
4:3, the mixture was dissolved in physiological saline and
diluted to form the solutions of 16.40 mg/mL, 32.60 mg/mL,
and 65.20 mg/mL extracts of LC (equivalent to 1.01 mg/mL,
2.02 mg/mL, and 4.04 mg/mL ferulic acid, and 1.75 mg/mL,
3.50mg/mL, and 7.00mg/mL senkyunolide I) and 48.40mg/mL
extracts of GE (equivalent to 7.19 mg/mL gastrodin), respec-
tively. All drug solutions were stored at 4C and shaken well
before use.
The DNS-Cl solution was prepared just before derivatiza-
tion by dissolving 80.00 mg of DNS-Cl in 10 mL of acetonitrile.
The borate buffer (pH 9.0; 0.2M) was prepared by dissolving
1.25 g of boric acid and 1.50 g sodium chloride in 100 mL of
ultrapure water, and 0.2M sodium hydroxide was added to
adjust the pH to 9.0.
2.5. Animals, drug administration, and sampling
Male SpragueeDawley rats (180e220 g) were supplied by the
Lab Animal Center of Shanghai University of Traditional
Chinese Medicine (SYXK (hu) 2008-0016), and were randomly
divided into six groups, named normal group, model group,
positive group, LCeGE (1:3) group, LCeGE (2:3) group, and
LCeGE (4:3) group, respectively. They were kept in an envi-
ronmentally controlled breeding room for 1 week before
starting the experiments, and fed with standard laboratory
food and water ad libitum. The animal facilities and protocols
were approved by the Institutional Animal Care and Use
Committee, Shanghai University of Traditional Chinese
Medicine. All procedures were conducted in accordance with
the Guide for the Care and Use of Laboratory Animal (The
National Academies Press, revised edition 2010). Excepting the
normal group, other groups of rats were subcutaneously
injected with 10 mg/kg of nitroglycerin to establish an
experimental rat migraine model as reported by Tassorelli
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orally administered to rats in each group at a dosage of 10 mL/
kg after 30 minutes, respectively. The rats in each group were
anesthetized at 15 minutes, 30 minutes, 60 minutes, and 120
minutes, respectively. Brains were rapidly removed after col-
lecting blood, and the brain samples were then stored at
80C.
The brains were homogenized in one volume of cold
physiological saline. An equal volume of 0.4 M perchloric acid
was added in an appropriate amount of homogenate, followed
by centrifugation (10,000 r/min for 10 minutes at 4C) to
remove the protein precipitate. Twenty microliters of the su-
pernatant was injected into the HPLC system for determina-
tion of 5-HT.
Another 50 mL of the supernatant was aspirated precisely
and put into a centrifuge tube; 1.0M sodium hydroxide (10 mL),
0.2M borate buffer (50 mL), and 8.00 mg/mL DNS-Cl solution
(50 mL) were added, and aftermixing vigorously for 10 seconds,
themixture was reacted in the dark at 30C in a water bath for
80 minutes. Then, an aliquot (40 mL) of acetic acid was added
into the tube to stop the reaction. The mixture was centri-
fuged at 4000 r/min for 5 minutes. The supernatant (10 mL) of
the reaction mixture was injected into the HPLC system for
determination of EAAs.
2.6. Optimization of the procedure for DNS-Cl
derivatization
Since both the 5-HT and EAAs have amino groups, the two
neurotransmitters in the brain tissues seem to be simulta-
neously determined by the derivative methods. However, the
5-HT itself has fluorescence, and there are large differences in
polarity between DNS-5-HT and DNS-L-Glu (or DNS-L-Asp),
which cost much time. Therefore, 5-HT and EAAs wereFig. 3 e Effect of pH value of borate buffer solution, DNS-Cl con
derivation reaction. L-Asp ¼ aspartate; DNS-Cl ¼ dansyl chloriddetermined separately. The reaction of EAAs with DNS-Cl
(Fig. 2) was optimized by using blank brain samples. Several
parameters were assayed: the borate buffer pH (pH 6.0e12.0);
the DNS-Cl concentration (0.5e12.0 mg/mL); temperature
(20e80C); and reaction time (5e120 min). After the derivati-
zation reaction, the peak area was recorded to evaluate the
optimal conditions.
2.7. Analytical method validation
2.7.1. Specificity
Interferences of endogenous and exogenous substances in rat
brain were investigated. The specificity of the method was
tested by comparing themixed reference standards and blank
brain samples for 5-HT, while for EAAs it occurred after the
derivatization reaction.
2.7.2. Linearity, limit of detection and limit of quantification
A series of standard solutions were obtained by further dilu-
tion of stock solution, through which the concentration for
serotonin and EAAs were in the range of 0.07e1.50 mg/mL and
1.25e480.00 mg/mL, respectively. The limit of detection (LOD)
and the limit of quantification (LOQ) of the method were
calculated from the signal-to-noise ratio, corresponding to
threefold and 10-fold of the noise level, respectively.
2.7.3. Precision, accuracy, recovery, and stability
The intrabatch precision was determined by analyzing six
replicates of each reference standard at concentrations of
0.10 mg/mL, 0.42 mg/mL, and 1.50 mg/mL for 5-HT and 2.50 mg/
mL, 16.00 mg/mL, and 240.00 mg/mL for EAAswhichwere added
to the blank brain samples on the same day. The interbatch
precisionwas determined by assaying six replicates daily over
3 consecutive days. The accuracy was assessed by expressingcentration, reaction temperature, and reaction time on
e; L-Glu ¼ glutamate; LU ¼ Luminous.
Fig. 4 e Representative chromatograms for the determination of serotonin with the mixed reference substances and brain
sample. 5-HIAA¼5-hydroxyindoleacetic acid; 5-HT¼5-hydroxytryptamine; 5-HTP¼5-hydroxytryptophan; LU¼ Luminous.
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nominal concentration, reflecting the difference between the
measured concentration and spiked concentration. Absolute
recoveries of 5-HT and EAAs were determined by comparing
the peak area ratio after extraction with those of unextracted
solutions containing the same concentrations of spiked 5-HT
and EAAs standards in rat brain. Stabilities of 5-HT and
EAAs in rat brain were examined after being kept at room
temperature for 24 hours, or undergoing one and two freeze-
ethaw cycles, six replicates were analyzed in one analytical
batch.
2.8. Statistical analysis
Data were expressed as the mean ± standard deviation. For
the comparisons of different groups sampled at sameFig. 5 e Representative chromatograms for the determination of
substances and brain sample after the derivatization reaction. D
L-Glu ¼ glutamate; LU ¼ Luminous.timeline, one-way analysis of variance and further Least-Sig-
nificant Difference (LSD) t multiple comparisons were
employed using Statistical Product and Service Solutions
(SPSS) for Windows, version 15.0 (SPSS Inc., Chicago, Illinois,
USA) A p value < 0.05 or p < 0.01 was taken to indicate sig-
nificant difference between data means.3. Results and discussion
3.1. Optimization of the procedure for DNS-Cl
derivatization
This reaction of EAAs with DNS-Cl was optimized by assaying
the borate buffer pH, the DNS-Cl concentration, temperature,
and reaction time. As can be seen from Fig. 3, the optimalthe excitatory amino acids (EAAs) with the mixed reference
NS ¼ dansyl; DNS-Cl ¼ dansyl chloride; L-Asp ¼ aspartate;
Table 1 e Linearity and sensitivity of detection for
serotonin and excitatory amino acids.
Analyte Regression
equation
Correlation
coefficient
LOD
(ng/mL)
LOQ
(ng/mL)
5-HTP Y ¼ 0.1999 X e 7.435 0.9998 0.8502 2.844
5-HIAA Y ¼ 0.1271 X e 12.66 0.9992 7.781 25.94
5-HT Y ¼ 0.1518 X e 11.71 0.9996 2.642 8.812
L-Glu Y ¼ 3.909 X þ 27.11 0.9998 108.6 361.9
L-Asp Y ¼ 3.522 X e 2.612 0.9999 94.38 314.6
5-HIAA ¼ 5-hydroxyindoleacetic acid; 5-HT ¼ 5-
hydroxytryptamine; 5-HTP ¼ 5-hydroxytryptophan; L-
Asp ¼ aspartate; L-Glu ¼ glutamate; LOD ¼ limit of detection;
LOQ ¼ limit of quantification.
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(pH 9.0; 0.2M), 8.0 mg/mL DNS-Cl, reaction temperature 30C,
and reaction time 80 minutes.
3.2. Analytical method validation
3.2.1. Specificity
Representative chromatograms for the determination of the
5-HT and EAAs in rat brain had showed that 5-HT and EAAs
were well separated, no interferences were detected from
endogenous substances, and the typical retention time for 5-
HTP, 5-HIAA, 5-HT were approximately 6.82 minutes, 11.18
minutes, and 11.86 minutes (Fig. 4); while for DNS-L-Glu and
DNS-L-Asp they were approximately 20.06 minutes and 21.45
minutes (Fig. 5).
The carboxyl in 5-HTP and 5-HIAA might cause baseline
instability and peak tailing, therefore, the mobile phase was
adjusted to pH 5.1 to inhibit dissociation. Due to the existence
of free carboxyl in the DNS-Cl derivatives, the two amino acids
were not separated well when the mobile phase was adjusted
to below pH 2.5. However, because 0.2mM tetrabutylTable 2 e Precision and accuracy of the method (n ¼ 6).
Analyte Spiked conc.
(mg/mL)
Intrabatch (n ¼ 6)
Measured conc.a
(mg/mL)
Accuracy (%)
5-HTP 0.10 0.10 ± 0.00 96.32
0.42 0.41 ± 0.01 97.62
1.50 1.44 ± 0.02 96.17
5-HIAA 0.10 0.10 ± 0.00 98.20
0.42 0.40 ± 0.01 95.24
1.50 1.48 ± 0.02 98.67
5-HT 0.10 0.10 ± 0.00 98.78
0.42 0.41 ± 0.02 97.62
1.50 1.50 ± 0.02 99.87
L-Glu 2.50 2.47 ± 0.03 98.80
16.00 15.96 ± 0.08 99.75
240.00 234.92 ± 0.87 97.88
L-Asp 2.50 2.44 ± 0.01 97.60
16.00 15.39 ± 0.04 96.19
240.00 237.43 ± 0.88 98.93
Conc. ¼ concentration; 5-HIAA ¼ 5-hydroxyindoleacetic acid; 5-HT ¼ 5-h
L-Glu ¼ glutamate: RSD ¼ relative standard deviation.
a Data expressed as mean ± standard deviation unless otherwise indicatammonium bromide was added into the ammonium acetate
buffer, the DNS-Cl derivative formed a new molecular-type
compound by combining the nitrogen positive ions, the two
amino acids were separatedmuch better, and the columnwas
unaffected by these ion-pairing reagents. Moreover, although
the hydrophobicity of L-Glu can be larger than that of L-Asp,
DNS-L-Glu was eluted earlier than DNS-L-Asp.
3.2.2. Linearity, LOD and LOQ
Good correlations were found between the peak areas (Y) and
the concentrations (X) using 1 or 1/X weighted linear least
squares regressionmodel (Table 1). The LODs for 5-HTP, 5-HT,
and 5-HIAA were 0.85e7.78 ng/mL (Signal/Noise (S/N) ¼ 3;
injection: 20 mL), while the LODs for L-Glu and L-Asp were
94.38e108.57 ng/mL (S/N ¼ 3; injection: 10 mL), and the LOQs
were 2.84e25.94 ng/mL (S/N ¼ 10; injection: 20 mL) and
314.61e361.90 ng/mL (S/N ¼ 10; injection: 10 mL), respectively,
which indicated that the methods were sensitive (Table 1).
3.2.3. Precision, accuracy, recovery, and stability
The accuracy and precision of themethods were examined by
using known amounts of reference standards. The results,
which are summarized in Table 2, meet the requirements of
accuracy within 95.00e105.00%, and precision relative stan-
dard deviation (RSD) < 5.00%. These results suggest that the
methods were accurate and precise. The recoveries of 5-HTP,
5-HT, and 5-HIAA were 93.41e107.12% with an RSD <2.56%;
meanwhile, L-Glu and L-Asp were 97.85e107.63% with an RSD
<4.18%. The results described above showed that the pro-
posed methods were reliable for the quality control of 5-HT
and EAAs. The stability RSD value for 5-HTP, 5-HT, and 5-
HIAA was approximately 2.63e7.50%, and that for L-Glu and
L-Asp was approximately 0.37e2.27% at room temperature
after 24 hours, first freezeethaw, and second freezeethaw,
respectively. It indicated that all five compounds were
considered stable in rat brain under different conditions.Interbatch (n ¼ 3)
Precision
RSD (%)
Measured conc.a
(mg/mL)
Accuracy (%) Precision
RSD (%)
0.52 0.10 ± 0.00 95.12 4.23
1.35 0.41 ± 0.02 96.53 4.88
1.39 1.46 ± 0.04 97.33 2.74
2.24 0.10 ± 0.00 97.03 2.83
2.38 0.41 ± 0.02 97.62 4.88
1.35 1.46 ± 0.03 97.33 2.05
1.55 0.10 ± 0.00 96.64 3.66
4.88 0.44 ± 0.02 104.76 4.55
1.33 1.53 ± 0.07 102.00 4.58
1.21 2.42 ± 0.08 96.80 3.31
0.50 15.67 ± 0.22 97.94 1.40
0.37 234.08 ± 5.21 97.53 2.23
0.41 2.43 ± 0.06 97.20 2.45
0.26 15.50 ± 0.11 96.88 0.71
0.37 248.21 ± 1.35 103.42 0.54
ydroxytryptamine; 5-HTP ¼ 5-hydroxytryptophan; L-Asp ¼ aspartate;
ed.
Table 3 e Amounts of 5-hydroxytryptophan (5-HTP) in rat brain (n ¼ 6).
Group 5-HTP
15 min 30 min 60 min 120 min
Normal group 641.72 ± 75.64a,b,c,* 690.12 ± 82.87a,b,c,** 619.87 ± 47.17a,b,c,* 624.36 ± 46.85a,b,c,*
Model group 639.78 ± 32.18a,b,c,* 693.42 ± 62.60a,b,c,** 619.63 ± 84.04a,b,c,* 652.40 ± 106.03a,b,*,c,**
Positive group 712.84 ± 58.08b,* 708.35 ± 42.79 677.16 ± 18.09a,**,b,c,* 683.96 ± 93.86a,b,**
LCeGE (1:3) group 779.35 ± 73.35d,e,* 781.29 ± 104.96d,e,** 764.06 ± 84.25d,e,*,f,** 793.75 ± 93.74d,e,*,f,**
LCeGE (2:3) group 852.53 ± 133.68d,e,f,* 792.94 ± 45.01d,e,** 817.82 ± 44.03d,e,f,* 798.53 ± 91.29d,e,*,f,**
LCeGE (4:3) group 799.25 ± 42.27d,e,* 780.20 ± 52.98d,e,** 804.72 ± 62.98d,e,f,* 772.80 ± 59.16d,*,e,f,**
Data are presented as (ng/g), mean ± standard deviation.
*p < 0.01.
**p < 0.05.
5-HTP ¼ 5-hydroxytryptophan; LCeGE ¼ Ligusticum chuanxiongeGastrodia elata.
a Statistically significant, other groups versus LC-GE (1:3) group.
b Statistically significant, other groups versus LC-GE (2:3) group.
c Statistically significant, other groups versus LC-GE (4:3) group.
d Statistically significant, other groups versus normal group.
e Statistically significant, other groups versus model group.
f Statistically significant, other groups versus positive group.
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The developedmethod for measuring 5-HT was applied to the
brain samples from rats. The rat brain 5-HT amounts
measured are shown in Tables 3e5. The results showed the
amounts of 5-HTP in LCeGE (1:3), (2:3), and (4:3) groups were
significantly higher than that of the model group at all sam-
pling times (p < 0.05 or p < 0.01). Similarly, the 5-HTmeasured
from the LCeGE (4:3) group was significantly higher than that
of the model group at all sampling times except 15 minutes (p
< 0.05 or p < 0.01), and the 5-HT measured from LCeGE (1:3)
and (2:3) groups were significantly higher than that of the
model group at 120minutes (p < 0.05). However, as for 5-HIAA,
there was no significant difference among LCeGE (1:3), (2:3),
and (4:3) groups and the model group at all sampling times.
Moreover, the amounts of 5-HT in the model group was
significantly lower than that of the normal group at all sam-
pling times (p < 0.01).Table 4 e Amounts of 5-hydroxytryptamine (5-HT) in rat brain
Group
15 min 30 min
Normal group 405.14 ± 47.76aee,* 377.31 ± 70.00a,
Model group 286.61 ± 39.56f,* 263.87 ± 16.27c,
Positive group 301.07 ± 33.50f,* 296.47 ± 39.31f,*
LCeGE (1:3) group 276.97 ± 46.80f,* 308.52 ± 52.42f,*
LCeGE (2:3) group 295.81 ± 78.51f,* 307.78 ± 29.49f,*
LCeGE (4:3) group 291.65 ± 17.05f,* 324.57 ± 29.01d,
Data are presented as (ng/g), mean ± standard deviation.
*p < 0.01.
**p < 0.05.
5-HT ¼ 5-hydroxytryptamine; LCeGE ¼ Ligusticum chuanxiongeGastrodia e
a Statistically significant, other groups vs. LC-GE (1:3) group.
b Statistically significant, other groups vs. LC-GE (2:3) group.
c Statistically significant, other groups vs. LC-GE (4:3) group.
d Statistically significant, other groups vs. model group.
e Statistically significant, other groups vs. positive group.
f Statistically significant, other groups vs. normal group.5-HT is one of the main transmitters in the nervous sys-
tem. Signaling of 5-HT is transmitted via receptors located on
neurons and many other cell types, and 5-HT1 receptor is the
one mainly expressed in the CNS, therefore, the 5-HT1D re-
ceptor agonist could suppress cerebral vasodilation and have
an effect on the treatment of migraine [24]. In this paper, it
was found that the experimental rat migraine model was
successfully established from this aspect by injecting nitro-
glycerin subcutaneously. Meanwhile, LCeGE 4:3 compatibility
could increase 5-HTP and 5-HT levels in migraine rat brain. As
the agonist of 5-HT1D receptor, the increase of 5-HT levelswas
conducive to migraine treatment. However, it could relieve
brain damage and decrease BBB permeability through inhib-
iting NMDA receptors. In addition, some drugs often had
timeliness when modulating the physiological function. It
was known that migraine occurred rapidly, and the main
active ingredients of LC and GE, namely senkyunolide I, ferulic
acid, and gastrodin, were absorbed quickly as well as(n ¼ 6).
5-HT
60 min 120 min
b,**,d,e,* 397.69 ± 44.62aee,* 415.04 ± 64.10aee,*
**,f,* 249.37 ± 46.33f,* 243.67 ± 22.50a,b,c,**,f,*
280.92 ± 33.00f,* 296.49 ± 40.15f,*
* 276.75 ± 45.33f,* 306.55 ± 64.07d,**,f,*
* 294.50 ± 49.86f,* 307.86 ± 55.61d,**,f,*
** 312.25 ± 41.71d,**,f,* 308.58 ± 33.68d,**,f,*
lata.
Table 5 e Amounts of 5-hydroxyindoleacetic acid (5-HIAA) in rat brain (n ¼ 6).
Group 5-HIAA
15 min 30 min 60 min 120 min
Normal group 578.33 ± 22.97 560.48 ± 25.25 547.36 ± 19.05 545.26 ± 22.25
Model group 576.44 ± 24.56 558.17 ± 14.01 541.16 ± 11.22 539.91 ± 16.27
Positive group 577.81 ± 23.60 557.86 ± 21.98 544.21 ± 23.86 521.64 ± 16.06*
LCeGE (1:3) group 587.25 ± 45.53 576.23 ± 27.58 557.33 ± 27.36 559.95 ± 22.92**
LCeGE (2:3) group 603.53 ± 29.61 573.61 ± 25.72 542.63 ± 28.01 546.83 ± 32.24
LCeGE (4:3) group 582.53 ± 28.70 566.28 ± 12.66 560.48 ± 40.42 549.46 ± 24.67
Data are presented as (ng/g), mean ± standard deviation.
*p < 0.01, other groups vs. LCeGE (1:3) group.
**p < 0.01, other groups vs. positive group.
5-HIAA ¼ 5-hydroxyindoleacetic acid; LCeGE ¼ Ligusticum chuanxiongeGastrodia elata.
Table 6 e The amounts of L-Glu in rat brain (n ¼ 6).
L-Glu
15 min 30 min 60 min 120 min
Normal group 770.42 ± 77.93 771.77 ± 83.96 778.01 ± 82.05a* 778.02 ± 66.14
Model group 873.25 ± 184.16 921.47 ± 83.88b,* 963.74 ± 136.67b,**,c,d,* 865.99 ± 88.24
Positive group 802.37 ± 94.89 797.07 ± 121.20 768.07 ± 92.84a,* 772.92 ± 122.42
LCeGE (1:3) group 778.11 ± 172.86 843.32 ± 222.96 816.33 ± 221.72 837.92 ± 140.43
LCeGE (2:3) group 818.99 ± 202.19 825.49 ± 168.18 884.01 ± 199.18b,** 878.43 ± 131.56
LCeGE (4:3) group 720.85 ± 278.16 725.14 ± 211.54a,* 626.25 ± 128.63a,e,** 720.00 ± 216.89
Data are presented as (mg/g), mean ± standard deviation.
*p < 0.05.
**p < 0.01.
LCeGE ¼ Ligusticum chuanxiongeGastrodia elata; L-Glu ¼ glutamate.
a Statistically significant, other groups vs. model group.
b Statistically significant, other groups vs. LC-GE (4:3) group.
c Statistically significant, other groups vs. normal group.
d Statistically significant, other groups vs. positive group.
e Statistically significant, other groups vs. LC-GE (2:3) group.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 1 8 9e1 9 8196eliminated fast, therefore, 120 minutes was the longest sam-
pling time to research timeliness. The results showed that,
compared with the pathological rat, the LCeGE 4:3 compati-
bility could increase 5-HT levels in migraine rat brain from 30Table 7 e The amounts of L-Asp in rat brain (n ¼ 6).
15 min 30
Normal group 718.05 ± 130.62 719.41
Model group 803.55 ± 187.25a,* 725.28
Positive group 751.72 ± 104.76 757.60
LCeGE (1:3) group 665.85 ± 154.91b,* 661.84
LCeGE (2:3) group 625.01 ± 100.31b,*,c,* 677.75
LCeGE (4:3) group 849.95 ± 131.31a,**,d,* 749.60
Data are presented as mg/g, mean ± standard deviation.
*p < 0.05.
**p < 0.01.
L-Asp ¼ aspartate; LCeGE ¼ Ligusticum chuanxiongeGastrodia elata.
a Statistically significant, other groups vs. LC-GE (2:3) group.
b Statistically significant, other groups vs. LC-GE (4:3) group.
c Statistically significant, other groups vs. model group.
d Statistically significant, other groups vs. LC-GE (1:3) group.minutes to 120minutes, while LCeGE 1:3 and 2:3 compatibility
could increase 5-HT levels at 120 minutes. It suggested that
LC-GE 4:3 compatibility may have better efficacy on upregu-
lating 5-HT levels than 1:3 and 2:3 compatibility.L-Asp
min 60 min 120 min
± 163.98 748.48 ± 120.56 750.50 ± 174.20
± 134.16 755.03 ± 109.54 762.75 ± 158.45
± 151.57 730.05 ± 162.30 770.89 ± 161.58
± 109.75 711.72 ± 178.39 664.90 ± 130.95
± 81.89 710.26 ± 152.72 697.40 ± 119.51
± 116.38 783.80 ± 105.64 837.41 ± 60.34
j o u r n a l o f f o o d and d ru g an a l y s i s 2 4 ( 2 0 1 6 ) 1 8 9e1 9 8 1973.4. Quantitative analysis of EAAs in rat brain
The amounts of the EAAs found in rat brain are presented in
Tables 6 and 7; the amounts of L-Glu in the LCeGE (4:3) group
was significantly lower than that of the model group at 30
minutes and 60 minutes (p < 0.05 or p < 0.01), and the L-Glu
measured from the LCeGE (4:3) group was significantly lower
than that of the LCeGE (2:3) group at 60 minutes (p < 0.01).
Meanwhile, the L-Asp measured from the LCeGE (4:3) group
was significantly higher than that of LCeGE (1:3) and (2:3)
groups at 15 minutes (p < 0.01). Moreover, the amounts of L-
Glu in normal and positive groups were significantly lower
than that of model group at 60 minutes (p < 0.05).
Glutamate receptors, activated by L-Glu and L-Asp, are
divided into two types including ionic and metabolic. Gluta-
mate ionotropic receptors of the NMDA and a-amino-3-
hydroxy-5-methyl-4-isoxazole-propionic acid/kainate type
are abundantly expressed on neurons and participate in the
regulation of both motor and secretory functions of the whole
body [25], while the metabotropic glutamate receptors are
involved in many developmental processes and immune and
synaptic functions, but the mode of their signal transduction
is unclear [26]. When the EAAs activate NMDA receptors, brain
damage can be caused. This paper showed that the experi-
mental rat migraine model was successfully established from
the L-Glu angle. Meanwhile, LCeGE 4:3 compatibility had
better efficacy on downregulating L-Glu levels in migraine rat
brain than 1:3 and 2:3 compatibility from 30 minutes to 60
minutes, and it had the same efficacy as the positive drug.4. Conclusion
In this paper, HPLC-fluorescence detector methods were
developed for the determination of two types of neurotrans-
mitters, which were closely related to migraine. The results
indicated that the methods were simple, sensitive, selective,
low cost, and could successfully measure five major neuro-
transmitters in rat brain, and that LCeGE 4:3 compatibility
could upregulate 5-HT levels from 30 minutes to 120 minutes
and downregulate L-Glu levels from 30 minutes to 60 minutes
in migraine rat brain. These findings provided further evi-
dence that there are possible pathways for Chinese medicine
to relieve brain damage and have an effect for treating
migraine.Conflicts of interest
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